Skip to main content
Back
Watch Compare

Keros Therapeutics, Inc.

Data quality: 100%
KROS
Nasdaq Manufacturing Chemicals
$11.21
▼ $1.29 (-10.29%)
Mkt Cap: 381.74 M
Price
$12.53
Mkt Cap
381.74 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 86.63% annually over 5 years — strong growth
ROE of 12.34% — decent returns on equity
Net margin of 35.68% shows strong profitability
Generating 105.95 M in free cash flow
P/E of 4.39 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6682.78%

Growth

Revenue Growth (5Y)
86.63%
Above sector avg (1.82%)
Revenue (1Y)6769.41%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
12.34%
Above sector avg (-53.53%)
ROIC8.88%
Net Margin35.68%
Op. Margin27.71%

Safety

Debt / Equity
N/A
Current Ratio29.86
Interest CoverageN/A

Valuation

PE (TTM)
4.39
Above sector avg (-1.48)
P/B Ratio0.54
EV/EBITDA-4.61
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1366 peers)
Metric Stock Sector Median
P/E 4.4 -1.5
P/B 0.5 1.6
ROE % 12.3 -53.5
Net Margin % 35.7 -41.5
Rev Growth 5Y % 86.6 1.8
D/E — 0.3

Analyst Price Target

7 analysts
Buy
Current
$11.21
+101.4%
Target
$22.57
$16.00
$20.00
$30.00
Forecast
Forward P/E -2.22
Forward EPS -$5.05
Est. Revenue 11.44 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$5.05
-$7.14 – -$3.66
 11.44 M 6
FY2026 -$4.67
-$7.21 – -$3.66
 3.13 M 6

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.45 -$0.86 -90.4%
Q32025 -$0.92 -$0.18 +80.5%
Q22025 -$1.13 -$0.76 +32.5%
Q12025 $0.01 $3.62 +48166.7%

ETFs Holding This Stock

BBC logo BBC Virtus Biotech Clinical Trials ETF
0.84% weight
VAMO VAMO
0.75% weight
QCSCX QCSCX
0.47% weight
QLSCX QLSCX
0.47% weight
QASCX QASCX
0.47% weight
QASGX QASGX
0.47% weight
QLSGX QLSGX
0.47% weight
QCSGX QCSGX
0.47% weight
QISGX QISGX
0.47% weight
FSCC logo FSCC Federated Hermes MDT Small Cap Core ETF
0.45% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 6769.41% Revenue Growth (3Y) 3918.70%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 86.63% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 243.86 M Net Income (TTM) 87.01 M
ROE 12.34% ROA 11.60%
Gross Margin N/A Operating Margin 27.71%
Net Margin 35.68% Free Cash Flow (TTM) 105.95 M
ROIC 8.88% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 29.86
Interest Coverage N/A Asset Turnover 0.33
Working Capital 695.22 M Tangible Book Value 703.58 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 4.39 Forward P/E N/A
P/B Ratio 0.54 P/S Ratio 1.57
PEG Ratio N/A Forward PEG N/A
EV/EBITDA -4.61 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 27.76%
Market Cap 381.74 M Enterprise Value -311.73 M
Per Share
EPS (Diluted TTM) 2.30 Revenue / Share 8.00
FCF / Share 3.48 OCF / Share 3.53
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.64% FCF Conversion 121.77%
SBC-Adj. FCF 75.75 M Growth Momentum 6682.78

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 243.86 M 3.55 M 151,000.0 0.0 20.10 M
Net Income 87.01 M -187.35 M -152.99 M -104.68 M -58.74 M
EPS (Diluted) 2.30 -5.00 -5.20 -4.15 -2.52
Gross Profit — — — — —
Operating Income 67.57 M -210.83 M -169.94 M -114.79 M -56.37 M
EBITDA — — — — —
R&D Expenses 129.64 M 173.63 M 135.26 M 87.27 M 55.14 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — 0.0 0.0 1,000.0 4,000.0
Income Tax 4.88 M 300,000.0 0.0 0.0 2.01 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 338.02 M 615.89 M 370.03 M 306.78 M 255.25 M
Total Liabilities 34.89 M 44.33 M 37.81 M 29.36 M 12.08 M
Shareholders' Equity 303.13 M 571.55 M 332.21 M 277.42 M 243.17 M
Total Debt — — — — —
Cash & Equivalents 287.42 M 559.93 M 331.15 M 279.05 M 230.04 M
Current Assets 315.43 M 588.89 M 347.29 M 285.77 M 251.44 M
Current Liabilities 20.41 M 27.45 M 24.37 M 16.55 M 11.85 M